Convulsions associated with prophylactic antimalarial drugs: implications for people with epilepsy.
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D002738:Chloroquine / Q000009:adverse effects; D003622:Dapsone / Q000009:adverse effects; D004827:Epilepsy / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D011739:Pyrimethamine / Q000009:adverse effects; D012640:Seizures / Q000139:chemically induced*; D013413:Sulfadoxine / Q000009:adverse effects
D000962:Antimalarials; D013413:Sulfadoxine; D002738:Chloroquine; D003622:Dapsone; D011739:Pyrimethamine